The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor

Nerve growth factor is a therapeutic candidate for Alzheimer’s disease. Due to its pain-inducing activity, in current clinical trials nerve growth factor is delivered locally into the brain by neurosurgery, but data on the efficacy of local nerve growth factor delivery in decreasing amyloid-β deposi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Brain
Päätekijät: Capsoni, Simona, Malerba, Francesca, Carucci, Nicola Maria, Rizzi, Caterina, Criscuolo, Chiara, Origlia, Nicola, Calvello, Mariantonietta, Viegi, Alessandro, Meli, Giovanni, Cattaneo, Antonino
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5379860/
https://ncbi.nlm.nih.gov/pubmed/28031222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/aww271
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia